5 related articles for article (PubMed ID: 38724585)
1. Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic Success.
Gunnellini M; Tornincasa A; Montedoro M; Caprodossi A; Prosperi E; Peverini M; Sarti AM; Aiuti S; Morini T
Anticancer Res; 2024 Jun; 44(6):2755-2758. PubMed ID: 38821608
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment.
Bardakci M; Karakas H; Bayram D; Avci N; Kitapli S; Ozen M; Aslan F; Koseoglu C; Kadioglu A; Onur ID; Sakalar T; Buyuksimsek M; Alkan A; Ergun Y; Kaya AO; Bilgin B; Yalcin B
Sci Rep; 2024 May; 14(1):10632. PubMed ID: 38724585
[TBL] [Abstract][Full Text] [Related]
3.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
4.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
5.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
